| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 18, 2010Data from FAST-PVI Study Presented at Cardiostim 2010
MINNEAPOLIS, & NICE, France, Jun 18, 2010 (BUSINESS WIRE) --Data from the FAST-PVI study, supported by Medtronic, Inc. (NYSE: MDT), shows lab time using anatomically-designed ablation catheters...
-
Jun 17, 2010New Data Released at Cardiostim 2010 Shows Benefits of Advanced Shock Reduction Technologies
MINNEAPOLIS & NICE, France, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced European launch of the Protecta(TM)portfolio of implantable cardioverter-defibrillators (ICDs)...
-
Jun 17, 2010
MINNEAPOLIS, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Securities 2010...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 31st Annual Healthcare...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the William Blair Growth Stock...
-
Jun 7, 2010iPro(TM)2 Professional CGM Provides Simple Way to Reveal Insights Into Glucose Control Not Possible With Standard Glucose Assessment Methods
MINNEAPOLIS, Jun 07, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) announced today the launch of iPro(TM)2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to...
-
Jun 2, 2010
MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
-
May 30, 2010Clinical Trial of Surgical Tissue Ablation Includes Two U.S. IDE Studies
MINNEAPOLIS, May 03, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant...
-
May 26, 2010Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial
PARIS, May 26, 2010 (BUSINESS WIRE) --New clinical data presented today at EuroPCR demonstrate positive long-term performance and durability for the CoreValve transcatheter aortic valve...
-
May 25, 2010International Revenue Growth of 20 Percent
MINNEAPOLIS, May 25, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT): First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP...
-
May 25, 2010Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe
PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...
-
May 25, 2010One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population
PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...
-
May 20, 2010Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern
MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...
-
May 20, 2010Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...
-
May 19, 2010Minimally-Invasive Procedure May Stabilize Aortic Bleeding When Surgery Is Not an Option
MINNEAPOLIS, May 19, 2010 (BUSINESS WIRE) --Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc. (NYSE: MDT), today announced that the...
-
May 17, 2010
MINNEAPOLIS, May 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May...
-
May 15, 2010Studies Presented at Heart Rhythm 2010 Demonstrate Advantages of Advanced Shock Reduction Technologies
MINNEAPOLIS & DENVER, May 15, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients...
-
May 14, 2010Shareholders Invited to Attend Annual Meeting on Aug. 25, 2010
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 14, 2010Trial Demonstrates Significant Decrease in Symptoms and Improved Quality of Life for AF Patients Treated with Arctic Front(R) Cardiac CryoAblation Catheter
MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...
-
May 13, 2010New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...
-
May 13, 2010Results of Virtual ICD Study Presented at Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients...
-
May 12, 2010Webcast Scheduled for 7 a.m. CDT, May 25, 2010
MINNEAPOLIS, May 12, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for its fourth quarter and fiscal year on Tuesday, May 25, 2010. A news...
-
May 10, 2010New Option to Connect Patients and Clinics Underscores Medtronic's Ongoing Efforts to Improve Clinic Efficiency and Simplify Patient Follow-up
MINNEAPOLIS, May 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) announced today that it now offers the new Medtronic M-Link(TM) cellular accessory, which provides cardiac device patients...
-
May 6, 2010RestoreSensor Neurostimulator Designed to Optimize Pain Relief for Patients Regardless of Body Position
MINNEAPOLIS, May 06, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced the initiation of a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensorTM...
-
Apr 29, 2010Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease
MINNEAPOLIS, Apr 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), and ATS Medical, Inc. (NASDAQ:ATSI), today announced that the companies have signed a definitive agreement under which...